Thor Advisors’s Pfizer PFE Stock Holding History

Thor Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-23,142	Closed	-$789K	–	182
2019 Q3	$789K	Buy	+23,142	New	+$842K	0.9%	37

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Thor Advisors's PFE Position: Q4 2019 in Review

Thor Advisors sold out of Pfizer (PFE) in Q4 2019, closing a stake of 23,142 shares — an estimated $789K sold.

Thor Advisors first reported a position in PFE in Q3 2019 and held it in 1 quarter. The position peaked at $789K in Q3 2019. 2,524 funds tracked by Wall St. Rank hold PFE as of Q4 2019.

Thor Advisors reported no remaining Pfizer position as of Q4 2019 after selling out during the quarter.
Thor Advisors sold 23,142 Pfizer shares in Q4 2019, an estimated $789K.
Thor Advisors first reported a position in Pfizer in Q3 2019 and held it in 1 quarter.
Thor Advisors's Pfizer position peaked at $789K in Q3 2019.
2,524 funds tracked by Wall St. Rank held Pfizer as of Q4 2019.

Based on Thor Advisors's 13F filing for Q4 2019, filed 18 Feb 2020.